Suzhou, June 13, 2025- The 2025 Chinese Pharmaceutical Society Pharmaceutical Bioanalysis Academic Annual Conference was grandly opened at the Suzhou High Speed Railway Jinke Hotel. This conference is hosted by the Pharmaceutical Bioanalysis Professional Committee of the Chinese Pharmaceutical Association, attracting experts and scholars from pharmaceutical companies, research institutes, medical institutions, and testing institutions to gather together for in-depth discussions on topics such as new biological analysis technologies, drug metabolism research, and laboratory management innovation. As a leading provider of laboratory full lifecycle services in China, Shanghai Yinzhi Scientific Instrument Co., Ltd. (hereinafter referred to as "Yinzhi Scientific Instrument") was invited to attend the conference and share its cutting-edge practices in laboratory intelligent relocation, equipment operation and maintenance, and biosafety management, becoming one of the focuses of the conference.

Focusing on the forefront of pharmaceutical and biological analysis, discussing the future of the industry together
The theme of this year's conference is "Promoting the Development of Pharmaceutical Bioanalytical Technology and Enhancing the Efficiency of Biomedical Research and Development", covering a variety of activities such as special lectures, presentations by young scholars, and sub venue discussions. The meeting focused on hot topics such as research strategies for novel biotechnological drugs ADME, clinical PK/PD analysis, and biomarker applications, with particular attention to the latest trends in efficient laboratory operations and safety management.
Duan Bo, Marketing Director of Yinzhike Instrument, delivered a keynote speech at the sub forum on "Laboratory Intelligent Management and Efficient Operation and Maintenance", detailing the company's innovative solutions in laboratory relocation, precision instrument maintenance, and biosafety risk control. He pointed out, "With the acceleration of biopharmaceutical research and development, the precision and intelligence of laboratory equipment continue to improve. Ensuring the stability of equipment during relocation, debugging, and daily operation has become a key challenge in the industry

Yinzhike Instrument showcases the laboratory's full lifecycle service capabilities
As one of the few service providers in China with the ability to relocate high-end laboratories, Yinzhike Instrument has accumulated rich experience in the field of pharmaceutical and biological analysis in recent years. In May 2025, the company successfully won the bid for the laboratory relocation project of Shanghai Jiao Tong University School of Medicine, with a contract amount of several million yuan. This project involves high-precision equipment such as liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS), as well as the safe transportation of pathogenic microorganism samples, fully demonstrating the company's professional management capabilities in complex laboratory environments.
At the conference, Yinzhike Instrument provided a detailed analysis of its full process service system, which includes pre relocation assessment, standardized disassembly and assembly, transportation safety, installation and commissioning, and after-sales support, through case sharing. The company adopts a hierarchical management strategy, dividing equipment into Level I (valuable precision equipment), Level II (ordinary precision equipment), and Level III (conventional equipment), and developing exclusive disassembly and assembly plans for different categories to ensure zero errors during the relocation process. In addition, in response to biosafety risks, the company has specially designed a cold chain logistics and specialized transportation plan for biological samples to ensure compliance with national laboratory safety regulations.
Collaboration between industry, academia, and research to promote the intelligent upgrading of laboratories
In addition to the laboratory relocation, Yinzhi Science Instrument also showcased its "Instrument New Life" second-hand scientific instrument trading platform, which adopts an innovative "post transaction fee" model, charging only 10% service fee, greatly reducing the equipment renewal cost of scientific research institutions. Duan Bo said, "The full lifecycle management of scientific instruments is not only related to the equipment itself, but also affects research efficiency and data reliability. We hope to help China's biopharmaceutical research and development reduce costs and increase efficiency through intelligent operation and maintenance, resource sharing, and circular economy models
During the conference, Yinzhike Instrument had in-depth exchanges with representatives from multiple pharmaceutical companies, CRO institutions, and university laboratories to explore the application of AIoT (Artificial Intelligence+Internet of Things) in laboratory equipment monitoring, as well as the future trends of modular laboratory construction. The company's technical team also demonstrated a remote device diagnostic system on site, which can monitor the real-time operation status of instruments, warn potential faults in advance, and significantly reduce the risk of laboratory downtime.

Looking ahead to the future: Laboratory services are moving towards intelligence and greenness
With the rapid development of China's biopharmaceutical industry, the demand for specialized and intelligent laboratory services continues to grow. The Yinzhi Scientific Instrument Plan aims to further expand intelligent monitoring, predictive maintenance, and low-carbon laboratory solutions, with the goal of becoming the largest scientific instrument circular economy ecological platform in China. Duan Bo emphasized, "In the context of the 'dual carbon' strategy, green operation and efficient utilization of scientific instruments will become the mainstream of the industry. We will continue to innovate and help Chinese scientific research institutions achieve sustainable development
This conference provides a valuable communication platform for experts and scholars in the field of pharmaceutical bioanalysis, and the participation of Yinzhike Instrument not only demonstrates its leading strength in laboratory services, but also provides new ideas for the intelligent upgrading of the industry. In the future, the company will continue to deepen cooperation with universities, research institutions, and enterprises to jointly promote the high-quality development of China's biopharmaceutical research and development.